Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud’s phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study

References

• Raynaud M. De l’asphyxie locale et de la gangrène symétrique des extrémités. Edition originale ed. Paris: L. Leclerc; 1862. p. 1862.
   Google Scholar
• Block JA, Sequeira W. Raynaud’s phenomenon. Lancet. 2001 Jun 23;357(9273):2042–2048. doi: 10.1016/S0140-6736(00)05118-7
   PubMed Web of Science ®Google Scholar
• Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison. J Rheumatol. 1997 May;24(5):879–889.
   PubMed Web of Science ®Google Scholar
• Brand FN, Larson MG, Kannel WB, et al. The occurrence of Raynaud’s phenomenon in a general population: the framingham study. Vasc Med. 1997 Nov;2(4):296–301. doi: 10.1177/1358863X9700200404
   PubMedGoogle Scholar
• Garner R, Kumari R, Lanyon P, et al. Prevalence, risk factors and associations of primary Raynaud’s phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015 Mar 16;5(3):e006389. doi: 10.1136/bmjopen-2014-006389
   PubMed Web of Science ®Google Scholar
• Fardoun MM, Nassif J, Issa K, et al. Raynaud’s phenomenon: a brief review of the underlying mechanisms. Front Pharmacol. 2016;7:438. doi: 10.3389/fphar.2016.00438
   PubMed Web of Science ®Google Scholar
• Fraenkel L, Zhang Y, Chaisson CE, et al. Different factors influencing the expression of Raynaud’s phenomenon in men and women. Arthritis Rheum. 1999 Feb;42(2):306–310.
   PubMedGoogle Scholar
• LeRoy EC, Medsger TA Jr. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol. 1992 Sep;10(5):485–488.
   PubMed Web of Science ®Google Scholar
• Maverakis E, Patel F, Kronenberg DG, et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmun. 2014 Feb;48–49:60–65.
   PubMed Web of Science ®Google Scholar
• Coral-Alvarado P, Pardo AL, Castaño-Rodriguez N, et al. Systemic sclerosis: a world wide global analysis. Clin Rheumatol. 2009 Jul;28(7):757–765.
   PubMed Web of Science ®Google Scholar
• Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017 Oct 7;390(10103):1685–1699. doi: 10.1016/S0140-6736(17)30933-9
   PubMed Web of Science ®Google Scholar
• Cutolo M, Pizzorni C, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol. 2005 Jun;19(3):437–452. doi: 10.1016/j.berh.2005.01.001
   PubMed Web of Science ®Google Scholar
• Paxton D, Pauling JD. Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review. Semin Arthritis Rheum. 2018 Dec;48(3):482–494. doi: 10.1016/j.semarthrit.2018.02.005
   PubMed Web of Science ®Google Scholar
• van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum. 2013 Nov;65(11):2737–2747.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Grassi W, Matucci Cerinic M. Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum. 2003 Nov;48(11):3023–30. doi: 10.1002/art.11310
   PubMedGoogle Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988 Sep;44(3):837–845. doi: 10.2307/2531595
   PubMed Web of Science ®Google Scholar
• Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatology (Oxford). 2005 May;44(5):587–96. doi: 10.1093/rheumatology/keh552
   PubMed Web of Science ®Google Scholar
• Ziegler S, Brunner M, Eigenbauer E, et al. Long-term outcome of primary Raynaud’s phenomenon and its conversion to connective tissue disease: a 12-year retrospective patient analysis. Scand J Rheumatol. 2003;32(6):343–7. doi: 10.1080/03009740410005007
   PubMed Web of Science ®Google Scholar
• Suter LG, Murabito JM, Felson DT, et al. The incidence and natural history of Raynaud’s phenomenon in the community. Arthritis Rheum. 2005 Apr;52(4):1259–63.
   PubMedGoogle Scholar
• Smith V, Vanhaecke A, Herrick AL, et al. Fast track algorithm: how to differentiate a “scleroderma pattern” from a “non-scleroderma pattern”. Autoimmun Rev. 2019 Nov;18(11):102394.
   PubMed Web of Science ®Google Scholar
• Smith V, Herrick AL, Ingegnoli F, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev. 2020 Mar;19(3):102458.
   PubMed Web of Science ®Google Scholar
• Seguro Paula F, Ferreira IA, Amaral MC, et al. Systemic sclerosis-related changes on nailfold videocapillaroscopy in genetic and metabolic myopathies. Rheumatology (Oxford). 2016 Oct;55(10):1911–2. doi: 10.1093/rheumatology/kew249
   PubMed Web of Science ®Google Scholar
• Cutolo M, Pizzorni C, Tuccio M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford). 2004 Jun;43(6):719–26.
   PubMed Web of Science ®Google Scholar
• Caramaschi P, Canestrini S, Martinelli N, et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford). 2007 Oct;46(10):1566–9.
   PubMed Web of Science ®Google Scholar
• Ingegnoli F, Boracchi P, Gualtierotti R, et al. Prognostic model based on nailfold capillaroscopy for identifying Raynaud’s phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination). Arthritis Rheum. 2008 Jul;58(7):2174–82. doi: 10.1002/art.23555
   PubMedGoogle Scholar
• Ingegnoli F, Gualtierotti R, Lubatti C, et al. Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations. Semin Arthritis Rheum. 2009 Feb;38(4):289–95.
   PubMed Web of Science ®Google Scholar
• Ingegnoli F, Boracchi P, Gualtierotti R, et al. Improving outcome prediction of systemic sclerosis from isolated Raynaud’s phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatology (Oxford). 2010 Apr;49(4):797–805.
   PubMed Web of Science ®Google Scholar
• Camargo CZ, Sekiyama JY, Arismendi MI, et al. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease. Scand J Rheumatol. 2015;44(1):48–55. doi: 10.3109/03009742.2014.926566
   PubMed Web of Science ®Google Scholar
• Ingegnoli F, Ardoino I, Boracchi P, et al. Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database. Microvasc Res. 2013 Sep;89:122–8.
   PubMed Web of Science ®Google Scholar
• Arana-Ruiz JC, Silveira LH, Castillo-Martínez D, et al. Assessment of nailfold capillaries with a handheld dermatoscope may discriminate the extent of organ involvement in patients with systemic sclerosis. Clin Rheumatol. 2016 Feb;35(2):479–82.
   PubMed Web of Science ®Google Scholar
• Sato LT, Kayser C, Andrade LE. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients. Acta Reumatol Port. 2009 Apr;34(2a):219–227.
   PubMedGoogle Scholar
• Marino Claverie L, Knobel E, Takashima L, et al. Organ involvement in Argentinian systemic sclerosis patients with “late” pattern as compared to patients with “early/active” pattern by nailfold capillaroscopy. Clin Rheumatol. 2013 Jun;32(6):839–43.
   PubMed Web of Science ®Google Scholar
• Ong YY, Nikoloutsopoulos T, Bond CP, et al. Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension. Asian Pac J Allergy Immunol. 1998 Jun;16(2–3):81–6.
   PubMed Web of Science ®Google Scholar
• Bredemeier M, Xavier RM, Capobianco KG, et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol. 2004 Feb;31(2):286–94.
   PubMed Web of Science ®Google Scholar
• Kayser C, Sekiyama JY, Próspero LC, et al. Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis. Clin Exp Rheumatol. 2013 Mar;31(2 Suppl 76):103–8.
   PubMed Web of Science ®Google Scholar
• Caetano J, Paula FS, Amaral M, et al. Nailfold videocapillaroscopy changes are associated with the presence and severity of systemic sclerosis-related interstitial lung disease. J Clin Rheumatol. 2019 Apr;25(3):e12–e15. doi: 10.1097/RHU.0000000000000815
   PubMed Web of Science ®Google Scholar
• Aschwanden M, Daikeler T, Jaeger KA, et al. Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease. Ann Rheum Dis. 2008 Jul;67(7):1057–9.
   PubMed Web of Science ®Google Scholar
• Fleming JN, Nash RA, McLeod DO, et al. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS One. 2008 Jan 16;3(1):e1452. doi: 10.1371/journal.pone.0001452
   PubMed Web of Science ®Google Scholar
• Sebastiani M, Manfredi A, Colaci M, et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum. 2009 May 15;61(5):688–94. doi: 10.1002/art.24394
   PubMedGoogle Scholar
• Sebastiani M, Manfredi A, Vukatana G, et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis. 2012 Jan;71(1):67–70.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Herrick AL, Distler O, et al. Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study. Arthritis & Rheumat. 2016 Oct;68(10):2527–39.
   PubMed Web of Science ®Google Scholar
• Pires NSM, Dantas AT, Duarte A, et al. Optical coherence tomography as a method for quantitative skin evaluation in systemic sclerosis. Ann Rheum Dis. 2018 Mar;77(3):465–466.
   PubMed Web of Science ®Google Scholar
• Babalola O, Mamalis A, Lev-Tov H, et al. Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis. Arch Dermatol Res. 2014 Jan;306(1):1–9.
   PubMed Web of Science ®Google Scholar
• Herrick AL, Berks M, Taylor CJ. Quantitative nailfold capillaroscopy-update and possible next steps. Rheumatology (Oxford). 2021 May 14;60(5):2054–2065. doi: 10.1093/rheumatology/keab006
   PubMed Web of Science ®Google Scholar
• Herrick AL, Dinsdale G, Murray A. New perspectives in the imaging of Raynaud’s phenomenon. Eur J Rheumatol. 2020 Oct;7(Suppl –3):S212–s221. doi: 10.5152/eurjrheum.2020.19124
   PubMedGoogle Scholar
• Cutolo M, Trombetta AC, Melsens K, et al. Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: proof of principle and validation in systemic sclerosis. Microcirculation. 2018 May;25(4):e12447.
   PubMed Web of Science ®Google Scholar
• Garaiman A, Nooralahzadeh F, Mihai C, et al. Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model. Rheumatology (Oxford). 2023 Jul 5;62(7):2492–2500. doi: 10.1093/rheumatology/keac541
   PubMed Web of Science ®Google Scholar
• Gracia Tello BC, Ramos Ibañez E, Saez Comet L, et al. External clinical validation of automated software to identify structural abnormalities and microhaemorrhages in nailfold videocapillaroscopy images. Clin Exp Rheumatol. 2023 Aug;41(8):1605–1611.
   PubMed Web of Science ®Google Scholar
• Berks M, Dinsdale G, Murray A, et al. Automated structure and flow measurement - a promising tool in nailfold capillaroscopy. Microvasc Res. 2018 Jul;118:173–177.
   PubMed Web of Science ®Google Scholar